fosbretabulin: Clinical Trials

11 trials of fosbretabulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated. 11 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 8, Terminated 3
Phase 13Terminated 2, Completed 1
Phase 31Terminated 1

Follow fosbretabulin: new trials by email Literature Review of fosbretabulin trials Research Report on fosbretabulin

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
fosbretabulin - Neuroendocrine Tumors
Phase 2CompletedMateon Therapeutics72014-12-012018-04-17
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
fosbretabulin tromethamine - Neuroendocrine Tumors
Phase 2CompletedMateon Therapeutics182014-09-012017-12-05
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
Pazopanib, Fosbretabulin - Ovarian Neoplasms, Neoplasms, Ovarian
Phase 1 / Phase 2TerminatedThe Christie NHS Foundation Trust212014-09-012021-05-17
Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
fosbretabulin, Saline - Polypoidal Choroidal Vasculopathy
Phase 2CompletedMateon Therapeutics202009-07-012011-11-01
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer
Fosbretabulin, Carboplatin, Paclitaxel - Tumors
Phase 2CompletedMateon Therapeutics632008-03-012015-02-09
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
CA4P, paclitaxel, carboplatin - Anaplastic Thyroid Cancer
Phase 2 / Phase 3TerminatedMateon Therapeutics802007-08-012014-06-09
Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Combretastatin A-4 Phosphate - Choroidal Neovascularization, Myopia, Degenerative
Phase 2CompletedMateon Therapeutics232005-03-012011-11-01
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
Combretastatin A-4 Phosphate + Paclitaxel + Carboplatin - Cancer, Tumor
Phase 2CompletedMateon Therapeutics132005-03-012011-11-01
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
filgrastim, pegfilgrastim, cisplatin - Head and Neck Cancer
Phase 1 / Phase 2TerminatedCase Comprehensive Cancer Center42003-11-012010-06-11
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
Combretastatin A-4 phosphate, Combretastatin A-4 Phosphate - Combretastatin A4 Phosphate, Age-related Macular Degeneration
Phase 1 / Phase 2CompletedJohns Hopkins University82003-05-012017-12-06
Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
fosbretabulin disodium - Head and Neck Cancer
Phase 2CompletedCase Comprehensive Cancer Center262003-02-012010-06-11

Conditions studied

Thyroid Carcinoma, Anaplastic (3)  ·  Choroidal Neovascularization (2)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms (2)  ·  Neuroendocrine Tumors (2)  ·  Thyroid Neoplasms (2)  ·  Carcinoid Tumor (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)  ·  Macular Degeneration (1)  ·  Myopia, Degenerative (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Ovarian Neoplasms (1)  ·  Polypoidal Choroidal Vasculopathy (1)

Sponsors

Mateon Therapeutics (7)  ·  Case Comprehensive Cancer Center (2)  ·  Johns Hopkins University (1)  ·  The Christie NHS Foundation Trust (1)

Countries

United States (9)  ·  United Kingdom (2)  ·  Belarus (1)  ·  Bulgaria (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Panayiotis Savvides, MD (2)  ·  Gordon Jayson (1)  ·  Gordon Rustin (1)  ·  Jai Balkissoon, MD, FACS (1)  ·  Julie A. Sosa, MD, FACS (1)  ·  Quan D Nguyen, MD, MSc (1)

Results publications

PMID 37816266, PMID 19265494, PMID 23316779, PMID 31932108

NIH funding

P30CA043703 (2)